Francesca Bonello
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 18
- Multiple Myeloma Research and Treatments 18
-
- Protein Degradation and Inhibitors 11
- Ubiquitin and proteasome pathways 3
- Cancer therapeutics and mechanisms 2
- Co-authors
- Mario Boccadoro (13 shared papers)Francesca Gay (5 shared papers)Roberto Mina (5 shared papers)Mattia D’Agostino (4 shared papers)Sara Bringhen (8 shared papers)Alessandra Larocca (6 shared papers)Chiara Cerrato (1 shared paper)Marco Salvini (3 shared papers)
- Journals
- Cancers (2 papers)Frontiers in Oncology (2 papers)Expert Review of Anticancer Therapy (2 papers)Expert Opinion on Biological Therapy (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- ItalySwitzerlandNetherlands
In The Last Decade
Francesca Bonello
17 papers receiving 181 citations
Peers
Comparison fields: 5 of 32
- Hematology 143
- Oncology 105
- Genetics 22
- Physiology 7
- Molecular Biology 103
Countries citing papers authored by Francesca Bonello
This map shows the geographic impact of Francesca Bonello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Bonello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Bonello more than expected).
Fields of papers citing papers by Francesca Bonello
This network shows the impact of papers produced by Francesca Bonello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Bonello. The network helps show where Francesca Bonello may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesca Bonello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2018 | 30 | |
| 3 | 2015 | 15 | |
| 4 | 2020 | 14 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2017 | 9 | |
| 10 | 2018 | 8 | |
| 11 | 2016 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2020 | 2 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 1 | |
| 18 | 2021 | 0 |
About Francesca Bonello
Francesca Bonello is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 181 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (11 papers), Peptidase Inhibition and Analysis (7 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Hematology (143 citations), Oncology (105 citations), Genetics (22 citations), Physiology (7 citations) and Molecular Biology (103 citations). Francesca Bonello has collaborated with scholars based in Italy, Switzerland and Netherlands. Frequent co-authors include Mario Boccadoro, Francesca Gay, Roberto Mina, Mattia D’Agostino, Sara Bringhen, Alessandra Larocca, Chiara Cerrato, Marco Salvini, Antonio Palumbo and Valeria Magarotto. Their work appears in journals such as Cancers, Frontiers in Oncology, Expert Review of Anticancer Therapy, Expert Opinion on Biological Therapy and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.